Does Spyre Therapeutics (SYRE) Pay a Dividend? (2026)
Short answer
Spyre Therapeutics (SYRE) pays little or no dividend; like many growth-oriented companies it reinvests cash rather than paying income. A dividend is a slice of profits returned to shareholders, and the yield is that payout divided by the share price, so it drifts as both change. Figures here are approximate; verify the current number with your broker.
Does Spyre Therapeutics (SYRE) pay a dividend?
Spyre Therapeutics (SYRE) currently returns little or nothing as a dividend. Spyre has no product revenue and posts steady losses funding R&D, so traditional earnings and valuation multiples do not apply (as of July 2026). Its roughly $8.2 billion market cap reflects expectations for its TL1A and IBD pipeline, not current cash flow. Investors weigh cash runway against clinical milestones rather than profits.
How to think about SYRE's dividend
- Yield is a snapshot: minimal today, but it moves with price and payout.
- Total return vs income: dividends are one part of return; price change is usually the bigger part for a name like SYRE.
- Reinvest or take income: a DRIP compounds; taking the cash gives income now.
- For more yield: dedicated dividend stocks and ETFs target higher payouts. See the best dividend ETFs.
The bottom line on the SYRE dividend
Spyre Therapeutics (SYRE) is not an income stock; if you own it, it is for growth or total return, not the dividend. For the full picture see the SYRE guide. Walnut can show how SYRE fits your real portfolio. It is not an investment adviser.
Build a basket around SYRE with Walnut
Use Spyre Therapeutics as one constituent in a thematic basket Walnut's AI helps you assemble. Describe a thesis you believe in, the AI proposes the holdings and weights, and you approve before any broker order.
FAQ
Does Spyre Therapeutics (SYRE) pay a dividend?
+
Spyre Therapeutics (SYRE) pays little or no dividend; like many growth-stage companies it tends to reinvest cash rather than return it as income. Verify the current policy on SYRE's investor relations page.
What is SYRE's dividend yield?
+
SYRE's yield is minimal or zero. Companies prioritizing growth often pay no dividend and return cash through buybacks instead, if at all.
How often does SYRE pay its dividend?
+
US companies that pay dividends, like Spyre Therapeutics if it does, typically distribute them quarterly. Confirm the exact schedule and ex-dividend dates on SYRE's investor relations page before relying on the timing.
Can I reinvest SYRE dividends?
+
Yes. Most brokers offer automatic dividend reinvestment (a DRIP) so any SYRE dividend buys more shares automatically. It compounds over time but is still taxable in a taxable account.
Is SYRE a good dividend stock?
+
Walnut is informational, not investment advice. SYRE is a growth or total-return name rather than an income stock. Dedicated dividend stocks and ETFs target higher, steadier yield; match the choice to whether you want income now or growth.
Does Spyre pay a dividend?
+
No. Spyre is an unprofitable clinical-stage company that reinvests all capital into research and development, so it pays no dividend. Any cash it raises goes toward funding trials rather than returning money to shareholders.
Walnut is informational, not investment advice. Dividend figures are approximate and dated; verify current yield, schedule, and policy with SYRE's investor relations page or your broker.